- Amarin Corporation (AMRN, Financial) will release its Q1 2025 financial results on May 7, 2025.
- An earnings conference call hosted by CEO Aaron Berg and the management team will follow at 8:00 a.m. ET.
- The call, including a Q&A session, will be accessible on Amarin's website and via dial-in options.
Amarin Corporation (AMRN), a leader in cardiovascular disease management, has announced its plans to release the financial results for the first quarter of 2025 on May 7, before market opening. This release will be followed by a conference call at 8:00 a.m. Eastern Time, during which Aaron Berg, President & CEO, alongside senior management, will review the quarterly performance and engage in a Q&A session.
Investors and interested parties can access the live call through the investor relations section on Amarin's website at www.amarincorp.com. For those wishing to dial in, the U.S. number is 888-506-0062, and the international number is 973-528-0011, using access code 253130.
For those unable to attend the live session, a replay of the call will be available. The U.S. replay number is 877-481-4010, while the international replay number is 919-882-2331, with the replay access code 52230. The replay will also be available on Amarin's website shortly after the event.
With offices in Bridgewater, New Jersey, and Dublin, Ireland, Amarin continues to propel forward the scientific understanding and treatment of cardiovascular risk beyond traditional therapies, maintaining a commitment to innovation and transparency in its operations and communications with shareholders.
